Protective immunity to diseases preventable by routine vaccination is lost over time following
allogeneic and autologous blood and marrow transplantation. Adoptive transfer of immunity …

Bacterial infections are a well-described complication of AIDS. However, relatively few
reports have described infections due to Pseudomonas aeruginosa in adults who are …

Recipients of allogeneic bone marrow transplantation are pancytopenic for several weeks
and immunosuppressed for many months as a result of myeloablative therapy required to …

Bone marrow transplant patients are at increased risk for infections with polysaccharide
encapsulated organisms and respond poorly to polysaccharide vaccines. We evaluated the …

Immunizing bone marrow donors prior to bone marrow transplant (BMT) has the potential for
adoptively transferring specific immunity against opportunistic pathogens. Studies have …

Allogeneic hematopoietic cell transplantation is followed by humoral immunodeficiency. We
evaluated whether antibody levels can be improved by recipient vaccination on day− 1 and …

Allogeneic bone marrow transplant patients are severely immunocompromised during the
immediate posttransplant period, and the risk for common and opportunistic infections may …

Advances in molecular immunology, biotechnology, and immunosuppressive pharmacology
have had a significant impact on human transplantation during the past decade. The number …

To obtain insight into the mechanism (s) of posttransplantation humoral immunodeficiency,
we evaluated factors affecting serum antibody levels against polio, tetanus, Haemophilus …

Adoptive transfer of immunity against hepatitis B surface antigen (HBsAg) has been
documented in mice and humans. In the present study, we report long-term follow-up of …